Starlix (nateglinide), a new oral tablet for type 2 diabetes

Novartis is now marketing Starlix (nateglinide), a new oral tablet for type 2 diabetes.

Think of it as a shorter-acting Prandin (repaglinide).

Both meds are taken before meals to stimulate insulin release...but Starlix has a shorter duration.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote